lyn's drug study

2
D D R R U U G G S S T T U U D D  Y  Y P PREPARED REPARED BY BY : N NALMALYN ALMALYN S. S S. SHALIM HALIM, BSN III – NCM 101, B, G , BSN III – NCM 101, B, GROUP ROUP # 8 # 8 Drug (Generic Name, Dosage, Route, Frequency & Indication) Brand Name Pharmacologic Action of the Drug Adverse/Side Effects of Drug Contrain- dications Nursing Responsibiities/Precauti ons 1. Oxytocin Parenteral, Classification: Oxytocic Drug Dosage: IV Infusi on (dri p method) For induction or stimulation of labor. Initial: 0.5-2 milli units/ min. Increase dose gradually in inc rements of no more than 1-2 milliunits/min at 30-60 min intervals until a con tracti on pat ter n has been established that is similar to labor. Rat es excee ding 9-10 milliunits/min are rarely required. Control of postpartum bl ee di ng: Add 10-40 uni ts (ma xi mum of 40 uni ts) to 1, 000 ml of a nonhydrating diluent and run at a rate needed to control uterine atony.  Treatment of  incomplete or inevitable abortion: Infuse ten units of oxytoci n with 500 mL physiological saline solution or D5W in NSS at a rate of 10-20 milliunits (20-40 dr ops /m in) . Do n ot exceed 30 units in a 12- Pitocin, Syntocinon Acts on smooth muscle of the uterus to stimulate contractions: response depends on the uterine threshold of excitability. Is selective for the uterus, especially toward the end of pregnancy, during labor, and immediately following delivery. It stimulates rhythmic contractions of the uterus, increases the frequency of existing contractions, and raises the tone of uterine musculature. CV: Cardiac arrhythmia, hypertensive episodes, PVCs GI: N&V, stomach pain, cramping CNS: Headache, dizziness GU: Pelvic hematoma, postpartum hemorrhage. Rupture of the uterus, spasm, titanic contraction, uterine hyper tonicity d/t excessive dosage or hypersensitivity to the drug. Hypersensitiv ity to drug. Significant CPD; unfavorable fetal positions or presentations that are undeliverable without conversion prior to delivery. In OB emergencies where the benefit- to-risk ratio for either the mother or fetus favors surgical intervention. Note reasons for therapy, onset, characteristics of S&S. Note any sensitivity to drug. Determine fetal maturity (size), pelvic adequacy, fetal presentation/position and lack of complications prior to initiatin drug therapy. Inform client for rationale of using oxytocic agents and reassure that this procedure is not unusual. Explain drug will induce contractions that may feel like menstrual cramps initially but can be very painful; analgesics may be given as needed. Oxytocin infusion should be discontinued immediately in the event of uterine hyperactivity or fetal distress. Give O2 for the mother.

Upload: nocreyes

Post on 30-May-2018

218 views

Category:

Documents


0 download

TRANSCRIPT

8/9/2019 Lyn's Drug Study

http://slidepdf.com/reader/full/lyns-drug-study 1/2

DD RR UU GG SS TT UU DD  Y  Y 

PPREPAREDREPARED BY BY :: NNALMALYNALMALYN S. SS. SHALIMHALIM, BSN III – NCM 101, B, G, BSN III – NCM 101, B, GROUPROUP # 8# 8

Drug(Generic Name,Dosage, Route,

Frequency &Indication)

BrandName

PharmacologicAction of the

Drug

Adverse/SideEffects of Drug

Contrain-dications

NursingResponsibiities/Preca

ons

1. Oxytocin

Parenteral,Classification:Oxytocic DrugDosage: IV Infusion (dripmethod) For induction orstimulation of labor.Initial: 0.5-2milliunits/min. Increasedose gradually inincrements of no morethan 1-2 milliunits/min at30-60 min intervals untila contraction pattern

has been establishedthat is similar to labor.Rates exceeding 9-10milliunits/min are rarelyrequired.

Control of postpartumbleeding: Add 10-40units (maximum of 40units) to 1,000 ml of anonhydrating diluent andrun at a rate needed tocontrol uterine atony.

  Treatment of  incomplete or inevitableabortion: Infuse ten unitsof oxytocin with 500 mLphysiological salinesolution or D5W in NSSat a rate of 10-20milliunits (20-40drops/min). Do notexceed 30 units in a 12-

Pitocin,

Syntocinon

Acts on smooth muscle

of the uterus tostimulate contractions:response depends onthe uterine threshold

of excitability. Isselective for the

uterus, especiallytoward the end of pregnancy, during

labor, and immediatelyfollowing delivery. Itstimulates rhythmic

contractions of theuterus, increases thefrequency of existing

contractions, andraises the tone of 

uterine musculature.

CV: Cardiac arrhythmia,

hypertensive episodes,PVCsGI: N&V, stomach pain,crampingCNS: Headache,dizzinessGU: Pelvic hematoma,postpartum hemorrhage.Rupture of the uterus,spasm, titaniccontraction, uterinehyper tonicity d/texcessive dosage or

hypersensitivity to thedrug.

Hypersensitivity to

drug. SignificantCPD; unfavorablefetal positions orpresentations thatare undeliverablewithout conversionprior to delivery. InOB emergencieswhere the benefit-to-risk ratio foreither the motheror fetus favorssurgical

intervention.

Note reasons for therapy, onset,

characteristics of S&S. Note any sensto drug.

Determine fetal maturity (size), pelvadequacy, fetal presentation/position lack of complications prior to initiatin therapy.

Inform client for rationale of usingoxytocic agents and reassure that thisprocedure is not unusual. Explain druginduce contractions that may feel likemenstrual cramps initially but can be painful; analgesics may be given as n

Oxytocin infusion should be discontimmediately in the event of uterinehyperactivity or fetal distress. Give O2

the mother.

8/9/2019 Lyn's Drug Study

http://slidepdf.com/reader/full/lyns-drug-study 2/2

hr period due to risk of water intoxication.

2.MagnesiumSulfateClassification:Anticonvulsant,Laxative and

SalineDosage: Seizures associatedwith eclampsia: 10-14g.

  To initiate therapy, 4gMagSul in water forinjection or 4-5g in 250ml of D5W or 0.9% NaClmay be given IV.

IV Infusion:Hypomagnesemia,severe: Adults: 5g(40mEq/L of D5Winjection of NaClinjection by slow infusion

over period of 3 hrs. Usecaution to preventexceeding renalexcretory capacity.

3. 

Epsom Salts  It is an essential

element for musclecontraction, certain

enzyme systems, andnerve transmission.Extracellular fluid

levels: 1.5-2.5 mEq/L.Mg depresses the CNS

and controlsconvulsions by

blocking release of acetylcholine at themyoneural junction,

MagnesiumIntoxication: Cardiac & CNSdepression preceding

respiratory paralysis,circulatory collapse,depressed reflexes,flaccid paralysis,flushing, hypotension,sweating.CNS: DepressionCV: Flushing,hypotension, circulatorycollapse, depression of the myocardium.

In the presence of heart block ormyocardialdamage. Intoxemia or

pregnancy duringthe 2 hr prior todelivery.

Reserve IV use in eclampsia forimmediate control of life-threateningconvulsions. Give slowly to avoid prodhypermagnesemia.

With premature labor, continually asfetal heart rate, intensity and timing o

contractions. Before administering IV check for thconditions:- absent patellar reflexes- respirations below 16/min- urine output <100 ml in past 4 hr- early signs of hypermagnesemia:

flushing, sweating, hypotensionmhypothermia.

- Past history of heart block ormyocardial damage; prolonged Pwidened QRS intervals in ECG she